Estrogen dermatitis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 72, Issue 1, 1997, Pages 97-103

  Leylek, Özkan A ^a   Ünlü, Sibel ^a   Öztürkcan, Serap ^a   Çetin, Ali ^a   Sahin, Mustafa ^a   Yildiz, Esin ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Autoimmune disease; Dermatitis; Estrogen; Progesterone; Sensitization; Sex hormones; Tamoxifen

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; TAMOXIFEN;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; FEMALE; HUMAN; PRIORITY JOURNAL; SENSITIZATION;

EID: 0031106894     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(96)02657-7     Document Type: Article

References (36)

1. [1] Shelley WB, Preucel RB, Spoont SS. Autoimmune progesterone dermatitis: Cure by oophorectomy. JAMA 1964; 190: 35-38.
2. [2] Tromovitch TA, Heeggli WF. Autoimmune progesterone urticaria. Calif Med 1967; 106: 211-212.
3. [3] Hart R. Autoimmune progesterone dermatitis. Arch Dermatol 1977; 113: 426-30.
4. [4] Farah FS, Shbaklu Z. Autoimmune progesterone urticaria. J Allergy Clin Immunol 1971; 48: 257-61.
5. [5] Geoggouras K. Autoimmune progesterone dermatitis. Aust J Dermatol 1981; 22: 109-112.
6. [6] Wojnarawska F, Greaves MW, Peachey RDG et al. Progesterone-induced erythema multiforme. J R Soc Med 1985; 78: 407-8.
7. [7] Jones WN, Gordon VH. Autoimmune progesterone eczema: An endogenous progesterone hypersensitivity. Arch Dermatol 1969; 99: 57-9.
8. [8] Katayama I, Nishioka K. Autoimmune progesterone dermatitis with persistent amenorrhea. Br J Dermatol 1992; 98: 601.
9. [9] Freychet F, Ortonne J-P. La dematose auto-immune a 1a progesterone. Ann Dermatol Venereol 1991; 118: 551-555.
10. [10] Stone J, Downham T. Autoimmune progesterone dermatitis. Int J Dermatol 1981; 20: 50-51.
11. [11] Miura T, Matsuda M, Yanbe H, Surgiyama S. Two cases of autoimmune progesterone dermatitis. Immunohistochemical and serological studies. Acta Derm Venerol 1989; 69: 308-310.
12. [12] Mc Burney EI, Noel SB, Collins JH. Contact dermatitis to transdermal estradiol system. J Am Acad Dermatol 1989; 20: 508-510.
13. [13] Ducros B, Bonnin JP, Navarranne A, Colomb D. Eczéma de contact à léthanol contenu dans une pastille d'oestradiol tansdamique. Nouc Dermatol 1989; 8: 21-22.
14. [14] Kelso JM, Keating MU, Squillace DL, O'Connell EJ, Yunginger JW, Sachs MI. Anaphylactoid reaction to ethanol. Ann Allergy 1990; 64: 452-454.
15. [15] Fisher AA. Systemic contact-type dermatitis. In: Fisher AA, ed. Contact Dermatitis, 3rd edn. Philadelphia: Lea and Febiger, 1986: 119-130.
16. [16] Allen LS, Mc Clure JE, Goldstein AL, Barkley MS, Michael SD. Estrogen and thymic hormone interactions in the female mouse. J Reprod Immunol 1984; 6: 25.
17. [17] Stimson WM, Crilly PJ. Effects of steroids on the secretion of immunoregulatory factors by thymic epithelial cell cultures. Immunology 1981; 44: 401.
18. [18] Shelley WB, Shelley ED, Talanin NV, Santosa-Pham J. Estrogen dermatitis. J Am Acad Dermatol 1995; 32: 25-31.
19. [19]Ferriman and Gallwey, Lorenzo, Hatch R, Rosenfleld RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815.
20. [20] Beynon HLC, Gorbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: Effect of intramuscular progesterone. Lancet 1988; 2: 370-372.
21. [21] Mayou SC, Charles-Homes R, Kenney A et al. A premenstrual urticarial eruption treated with bilateral oophorectomy and hysterectomy. Clin Exp Dermatol 1988; 13: 114-116.
22. [22] Mabray CR, Burditt ML, Martin TL et al. Treatment of common gynecologic-endocrinologie symptoms by allergy management procedures. Obstet Gynecol 1982; 59: 560-564.
23. [23] Hasslguist MB, Goldberg N, Schroeter A et al. Isolation and characterization of the estrogens receptor in human skin. J Clin Endocrinol Metab 1980; 50: 76-82.
24. [24] Helgason S, Wilking N, Caristram K, Domber MG, Von Schoultz BA. comparative study of the estrogenic effects of tamoxifen and 17β estradiol in postmenopausal women. J Clin Endocrinol Metab 1982; 54: 404.
25. [25] Jordan VC, Murphy CS. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 1990; 11: 578.
26. [26] Boccardo F, Guarnieri D, Rubagotti A, et al. Endocrine effects of tamoxifen on postmenopausal breast cancer patients. Tumor 1984; 76: 61.
27. [27] Early Breast Cancer Trialists Collaborative Group, Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 1992; 339: 71-85.
28. [28] De Muylder X, Neven P, DeSome M, Van Belle Y, Vandearick G, De Muylder E. Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Obstet 1991; 36: 127.
29. [29] Gal D, Kopel S, Bashevkin M, et al. Oncogenic potential of tamoxifen on endometrial of postmenopausal women with breast cancer-Preliminary report. Gynecol Oncol 1991; 42: 120.
30. [30] Neven P, De muylder X, Van Belle Y, et al. Tamoxifen and the uterus and endometrium. Lancet 1989; 1: 375-376.
31. [31] Malfetano JH. Tamoxifen-associated endometrial carcinoma in postmenopasual breast cancer patients. Gynecol Oncol 1996; 39: 82.
32. [32] Formander T, Cedermark B, Mattson A, et al. Adjuvant tamoxifen in early breast cancer. Occurrence of new primary cancers. Lancet 1989; 8630: 117.
33. [33] Hardell L. Tamoxifen as a risk factor for carcinoma of corpus uteri. Lancet 1988; 3: 563.
34. [34] Killacke MA, Hakes TB, Pierce VK. Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treat Rep 1985; 69: 237.
35. [35] Nolvadex Adjuvant Trial Organization. Controlled trial of tamoxifen as a single adjuvant agents in the management of early breast cancer. Br J Cancer 1988; 57: 608.
36. [36] Riberio G, Swindell R. Christie Hospital Adjuvant Tamoxifen Trial. Br J Cancer 1988; 57: 601.